| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -162.09M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, SMMT returned -49.8% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -24.8% |
| 1 year | -49.8% |
| 5 years | +65.1% |
| 10 years | +98.2% |
| All-time high | $26.37 (Jul 2025) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in SMMT would be worth today ›No. Summit Therapeutics Inc. has not paid a dividend in the past 12 months.
Summit Therapeutics Inc. stock trades on NASDAQ under the ticker symbol SMMT.
Summit Therapeutics Inc. is part of the Healthcare sector.
Summit Therapeutics Inc. has a market cap of 10.50B USD, based on the latest quote.
Summit Therapeutics Inc. is expected to report earnings around Oct 19, 2026. That date is an estimate and has not been confirmed by the company.
